What is the Drug Discovery Market Size?
According to 6Wresearch internal database and industry insights, the
Global drug discovery market was valued at approximately USD 78.6 billion in 2024 and is projected to reach USD 138.4 billion by 2031. The market is anticipated to grow at a CAGR of 8.3% during the forecast period.
This growth is driven by technological advancements in high-throughput screening, increasing R&D investments, and rising demand for targeted and personalized medicine. Additionally, growing collaborations between pharmaceutical companies and research institutions are expediting the drug discovery and development process.
Key Growth Factors of the Drug Discovery Market
- Increasing healthcare expenditure and demand for novel therapies
- Advancements in genomics, AI, and bioinformatics in drug discovery
- Expansion of pharmaceutical R&D and strategic collaborations
- Rise in chronic diseases and drug-resistant infections
- Growth of biologics and biosimilars in therapeutic pipelines
- Government incentives and regulatory support for new drug development
Drug Discovery Market Trends
The market is witnessing integration of artificial intelligence and machine learning for faster molecule identification. Outsourcing of drug discovery processes is increasing, and there is a strong focus on precision medicine. Biopharmaceutical companies are investing in advanced platforms like CRISPR and organ-on-chip technologies. Cloud-based data analytics is also shaping R&D strategies.
Emerging Developments in the Drug Discovery Market
New technologies such as quantum computing and AI-powered drug design are accelerating lead compound identification. Startups are disrupting the market with niche approaches like fragment-based drug design. There is also a surge in collaborative platforms combining academic and commercial resources, and increasing use of automation in laboratory workflows.
Major Companies in the Drug Discovery Market
- Pfizer Inc.
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- AstraZeneca plc
- Merck & Co., Inc.
Drug Discovery Market Size : FAQ's
The drug discovery market is expected to reach USD 138.4 billion by 2031.
AI, machine learning, high-throughput screening, and CRISPR-based platforms are at the forefront of innovation.
Rising chronic diseases, increased R&D funding, and the shift toward personalized medicine are major drivers.
Oncology, neurology, infectious diseases, and immunology are among the top therapeutic focus areas.
Pharmaceutical firms are increasingly outsourcing early-stage R&D to CROs and biotech firms for cost and speed benefits.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com